- Home
- MLSS vs BRNS Comparison
MLSS vs BRNS Comparison
Compare MLSS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLSS
- BRNS
- Stock Information
- Founded
- MLSS 1989
- BRNS 2016
- Country
- MLSS United States
- BRNS United Kingdom
- Employees
- MLSS N/A
- BRNS N/A
- Industry
- MLSS Industrial Specialties
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MLSS Health Care
- BRNS Health Care
- Exchange
- MLSS Nasdaq
- BRNS Nasdaq
- Market Cap
- MLSS 42.4M
- BRNS 48.3M
- IPO Year
- MLSS 1995
- BRNS 2021
- Fundamental
- Price
- MLSS $0.55
- BRNS $1.07
- Analyst Decision
- MLSS Buy
- BRNS Strong Buy
- Analyst Count
- MLSS 1
- BRNS 1
- Target Price
- MLSS $1.25
- BRNS $3.00
- AVG Volume (30 Days)
- MLSS 58.0K
- BRNS 42.9K
- Earning Date
- MLSS 11-13-2025
- BRNS 11-05-2025
- Dividend Yield
- MLSS N/A
- BRNS N/A
- EPS Growth
- MLSS N/A
- BRNS N/A
- EPS
- MLSS N/A
- BRNS N/A
- Revenue
- MLSS $9,083,205.00
- BRNS $14,969,000.00
- Revenue This Year
- MLSS $17.24
- BRNS N/A
- Revenue Next Year
- MLSS $14.58
- BRNS N/A
- P/E Ratio
- MLSS N/A
- BRNS N/A
- Revenue Growth
- MLSS 7.84
- BRNS 1766.46
- 52 Week Low
- MLSS $0.38
- BRNS $0.64
- 52 Week High
- MLSS $1.39
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- MLSS 39.70
- BRNS 41.80
- Support Level
- MLSS $0.55
- BRNS $1.08
- Resistance Level
- MLSS $0.65
- BRNS $1.20
- Average True Range (ATR)
- MLSS 0.04
- BRNS 0.10
- MACD
- MLSS -0.00
- BRNS -0.01
- Stochastic Oscillator
- MLSS 0.90
- BRNS 22.16
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.